https://journals.lww.com/jasn/fulltext/2012/11000/treatment_of_primary_fsgs_in_adults.5.aspx#:~:text=The%20treatment%20options%20for%20relapsing,for%20relapsing%20minimal%2Dchange%20disease.&text=These%20include%20another%20course%20of,%5BCSA%5D%20or%20tacrolimus).
Hey Duke I think Rituximab is not the standard of care. Have a look at above article.
https://journals.lww.com/jasn/fulltext/2012/11000/treatment_of_pr...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $189.6M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.8¢ | 33.5¢ | $2.114M | 6.083M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 516070 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 3146 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.5¢ |
Change
-0.005 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| 35.5¢ | 36.0¢ | 33.5¢ | 3852478 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| DXB (ASX) Chart |